HIV & AIDS

Vaccine regimen fails to prevent HIV-1 infection in South Africa

(HealthDay)—A canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, according to a study published in the March 25 issue ...

Vaccination

Switzerland approves J&J COVID vaccine

Swiss regulators on Monday gave the green light to Johnson & Johnson's COVID-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Moderna.

Diseases, Conditions, Syndromes

AstraZeneca: US data shows vaccine effective for all adults

AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world ...

page 38 from 40